Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Kenneth J. Kelley currently holds 179,833 shares of HALOZYME THERAPEUTICS INC (HALO), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Kenneth J. Kelley has been a net seller of HALO stock. They have purchased $1.0M and sold $7.8M worth of shares.
Kenneth J. Kelley's most recent insider trade was on Apr 14, 2021, when they sold 5,000 shares at $45.00 per share.
Kenneth J. Kelley serves as Executive at HALOZYME THERAPEUTICS INC (HALO). They have executed 257 insider transactions totaling $8.8M over their tenure at the company.
Kenneth J. Kelley holds the position of Executive at HALOZYME THERAPEUTICS INC, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 20 years and currently hold a stake valued at $0.
Kenneth J. Kelley has shown a selling trading pattern, with $1.0M in total purchases and $7.8M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Kenneth J. Kelley was on Dec 7, 2020, when they sold $1.4M worth of HALO shares. This transaction involved 35,086 shares at $41.00 per share.
Kenneth J. Kelley currently owns 179,833 shares of HALOZYME THERAPEUTICS INC (HALO), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Kenneth J. Kelley's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Kenneth J. Kelley has 257 Form 4 filings on record as an insider at HALOZYME THERAPEUTICS INC.
Set alerts for Kenneth J. Kelley and 40,000+ other insiders.